Dr. Walaa Elsalakawy

Consultant Internal Medicine

Work Experience

• Dr Walaa has nearly 25 years of medical experience in the field of internal medicine.
• She has earned her graduation from the faculty of medicine, Ain Shams University, Cairo, Egypt in 2001.
• She received her master’s degree in Nov 2005 and earned her doctoral degree in internal medicine in Nov 2009.
• She worked as a consultant of internal medicine and hematology in many hospitals inside Egypt including the Ain Shams University hospitals with nearly 15 years of experience after MD.
• She works as a professor of internal medicine and hematology in Ain shams University since 2020.
• She has extensive experience teaching undergraduate and postgraduate students. Additionally, Dr Walaa has published a book series on various branches of internal medicine titled “The Approach in internal Medicine”

Languages Spoken

• English
• Arabic

Special Interests

• Diabetes and its complications
• Thyroid diseases
• Hypertension and its complications
• Chest Pain
• Gastrointestinal diseases and malabsorption syndromes
• Abnormal liver function tests and viral infections of the liver (hepatitis virus), fatty liver.
• Anemias (inherited or acquired causes) e.g. hemolysis- sickle cell anemia – G6PD anemia- iron and B12 deficiency anemia
• Bleeding and skin bruising
• Thrombosis, DVT and recurrent abortions (medical causes)
• Immunity disorders , recurrent infections
• Abnormalities in blood cells (red blood cells, white blood cells or platelets)
• Abnormalities of blood proteins.
• Diabetic nephropathy- chronic kidney disease
• Systemic lupus erythromatosis- rheumatoid arthritis- joint inflammation and pain

Research and Publications

As a university staff and a professor, dr Walaa has designed and supervised many articles that was published in international and national journals

EHA (European Hematology Association) publications

• Serum follistatin level as a prognostic marker in Haploidentical stem cell transplantation
• Value of vanin-1 assessment in adult patients with primary immune thrombocytopenia
• ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate
• First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
• First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients
• Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload
• Assessment of B-lymphocyte and T-lymphocyte function in patients with myelodysplastic syndromes
• Leukemia stem cell markers (CD 123 and CD25) are poor prognostic markers in patients with adult acute myeloid leukemia
• Predictive value of the proliferation marker Ki-67 in patients with acute leukemia undergoing hematopoietic stem cell transplantation
• Flow cytometric evaluation of CD200 as a tool for differentiation between chronic lymphocytic leukemia and mantle cell lymphoma
• Blood indices to differentiate between β-thalassemia trait and iron deficiency anemia in adult healthy Egyptian blood donors
• High levels of soluble thrombomodulin may be a marker of arterial disease and peripheral ischemia in Egyptian patients with diabetes mellitus
• Cost-effectiveness of postremission intensive chemotherapy in comparison with allogeneic stem-cell transplantation in adult Egyptian patients with acute myeloid leukemia
• Prognostic significance of intracellular survivin in myeloid blast cells as an inhibitor of apoptosis in Egyptian adult acute myeloid leukemia patients